Report: TriVentures Raises $75M Fund

May 18, 2015 | According to a “Calcalist” report, the Israeli life sciences venture capital firm TriVentures raised $75 million for its third fund, with the goal of raising up to $100 million. The fund currently manages about $100 million total, raised in its first two funds. Major investors participated in the third fund, including Medtronic, Johnson & Johnson, and other large health providers, as well as Samsung and Nikon. TriVentures was founded by Michal Geva and is headquartered in Herzliya, Israel.